Growing prevalence of Providencia stuartii associated with the increased usage of colistin at a tertiary health care center

Summary From 2005 to 2009, at Detroit Medical Center, the prevalence of Providencia stuartii increased from 0.52 to 0.91/1000 patient-days ( p < 0.001). The use of colistin also increased ( p < 0.001) during the study period. The increase in the prevalence of P. stuartii was associated with an...

Full description

Saved in:
Bibliographic Details
Published in:International journal of infectious diseases 2012-09, Vol.16 (9), p.e646-e648
Main Authors: Hayakawa, Kayoko, Marchaim, Dror, Divine, George W, Pogue, Jason M, Kumar, Sarwan, Lephart, Paul, Risko, Ken, Sobel, Jack D, Kaye, Keith S
Format: Article
Language:English
Subjects:
Anti-Bacterial Agents - administration & dosage
Anti-Bacterial Agents - adverse effects
Antimicrobial resistance
Colistin
Colistin - administration & dosage
Colistin - adverse effects
Drug Resistance, Multiple, Bacterial
Enterobacteriaceae Infections - drug therapy
Enterobacteriaceae Infections - epidemiology
Female
Gram-negative bacteria
Humans
Infectious Disease
Logistic Models
Michigan - epidemiology
Middle Aged
Minocycline - administration & dosage
Minocycline - adverse effects
Minocycline - analogs & derivatives
Prevalence
Providencia - isolation & purification
Providencia stuartii
Pulmonary/Respiratory
Retrospective Studies
Tertiary Care Centers
Tigecycline
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Summary From 2005 to 2009, at Detroit Medical Center, the prevalence of Providencia stuartii increased from 0.52 to 0.91/1000 patient-days ( p < 0.001). The use of colistin also increased ( p < 0.001) during the study period. The increase in the prevalence of P. stuartii was associated with an increased use of colistin ( p < 0.001). Facilities that frequently use colistin and tigecycline should closely monitor the prevalence of P. stuartii along with other Proteeae, since these organisms are intrinsically resistant to colistin and tigecycline.
ISSN:1201-9712
1878-3511
DOI:10.1016/j.ijid.2012.05.1029